Steven R. Cummings, MD, FACP

Education

Stanford University, Stanford, CA, B.A., 1969, Psychology
Union Theological Seminary, N.Y., N.Y., (no degree), 1970, Ethics
University of California San Francisco, M.D., 1976, Medicine

Honors & Awards

• 1985-1990
  Henry J. Kaiser Faculty Fellowship Award in General Internal Medicine
• 1988-present
  Board of Directors, National Osteoporosis Foundation
• 1990-1994
  Advisory Panel on Osteoporosis, US Congress, Office of Technology Assessment
• 1990-present
  Elected Faculty AOA
• 1991-present
  Member, Scientific Advisory Board, National Osteoporosis Foundation
• 1992-1993
  Consultant, World Health Organization (assigned to China)
• 1995-present
  National Osteoporosis Foundation Clinical Guidelines Core Committee
• 1996-present
  Elected, American Association of Physicians (AAP)
• 1996-present
  Elected, Council of American Society for Bone & Mineral Research (ASBMR)

Selected Publications

1. Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.  View on PubMed
2. Publisher Correction: A meta-analysis of genome-wide association studies identifies multiple longevity genes.  View on PubMed
3. Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.  View on PubMed
4. Cummings SR Clinical Trials Without Clinical Sites.  View on PubMed
5. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.  View on PubMed
6. Kim KM, Lui LY, Cauley JA, Ensrud KE, Orwoll ES, Schousboe JT, Cummings SR Response to "Red Cell Distribution Width Is a Risk Factor for Hip Fracture in Elderly Men Without Anemia".  View on PubMed
7. Cummings SR, Eastell R Authors' response to KD Stathopoulos regarding "Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures".  View on PubMed
8. Kleinstern G, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Bertrand KA, Norman AD, Visscher DW, Couch FJ, Brandt K, Shepherd J, Wu FF, Chen YY, Cummings SR, Winham S, Kerlikowske K, Vachon CM Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes.  View on PubMed
9. Cawthon PM, Blackwell T, Cummings SR, Orwoll ES, Duchowny KA, Kado DM, Stone KL, Ensrud KE, Cauley JA, Evans WJ Muscle Mass Assessed by the D3-Creatine Dilution Method and Incident Self-reported Disability and Mortality in a Prospective Observational Study of Community-Dwelling Older Men.  View on PubMed
10. Burden AM, Tanaka Y, Xu L, Ha YC, McCloskey E, Cummings SR, Glüer CC Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review.  View on PubMed
11. Duan Y, Evans DS, Miller RA, Schork NJ, Cummings SR, Girke T signatureSearch: environment for gene expression signature searching and functional interpretation.  View on PubMed
12. Cosman F, Peterson LR, Towler DA, Mitlak B, Wang Y, Cummings SR Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.  View on PubMed
13. Orwoll ES, Wiedrick J, Nielson CM, Jacobs J, Baker ES, Piehowski P, Petyuk V, Gao Y, Shi T, Smith RD, Bauer DC, Cummings SR, Lapidus J Proteomic assessment of serum biomarkers of longevity in older men.  View on PubMed
14. Almog YA, Rai A, Zhang P, Moulaison A, Powell R, Mishra A, Weinberg K, Hamilton C, Oates M, McCloskey E, Cummings SR Deep Learning With Electronic Health Records for Short-Term Fracture Risk Identification: Crystal Bone Algorithm Development and Validation.  View on PubMed
15. Cawthon PM, Orwoll ES, Ensrud KE, Cauley JA, Kritchevsky SB, Cummings SR, Newman A Assessing the Impact of the COVID-19 Pandemic and Accompanying Mitigation Efforts on Older Adults.  View on PubMed
16. Kim KM, Lui LY, Browner WS, Cauley JA, Ensrud KE, Kado DM, Orwoll ES, Schousboe JT, Cummings SR Association between variation in red cell size and multiple aging-related outcomes.  View on PubMed
17. Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR, Eastell R Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis.  View on PubMed
18. Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, Magaziner JM, Newman AB, Brown T, Kiel DP, Cummings SR, Shardell M, Guralnik JM, Woodhouse LJ, Pahor M, Binder E, D'Agostino RB, Quian-Li X, Orwoll E, Landi F, Orwig D, Schaap L, Latham NK, Hirani V, Kwok T, Pereira SL, Rooks D, Kashiwa M, Torres-Gonzalez M, Menetski JP, Correa-De-Araujo R, Bhasin S Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference.  View on PubMed
19. Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements.  View on PubMed
20. Schafer MJ, Zhang X, Kumar A, Atkinson EJ, Zhu Y, Jachim S, Mazula DL, Brown AK, Berning M, Aversa Z, Kotajarvi B, Bruce CJ, Greason KL, Suri RM, Tracy RP, Cummings SR, White TA, LeBrasseur NK The senescence-associated secretome as an indicator of age and medical risk.  View on PubMed

Go to UCSF Profiles, powered by CTSI